RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
Back to Home
MFDS (South Korea)
NOTICE
「의약품동등성시험기준」 일부개정 고시 알림
Published: 2/13/2026Detected: 3/26/2026

Summary preview

Provides an official notice regarding amendments to the MFDS “Guidelines for Bioequivalence (Drug Product Equivalence) Testing.” It indicates that regulated parties should review the updated requirements because they…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
clinical
manufacturing
quality
safety
labeling
#MFDS
#drug equivalence testing
#bioequivalence
#generic drug
#clinical study

Official Source Document
Source Verified

Access the original document directly from MFDS.

View Official Document

More from MFDS (South Korea)

  • 「의료기기법 시행규칙」 일부개정령(안) 입법예고(식품의약품안전처 공고 제2026-445호)9/14/2026
  • 「의약외품 품목허가·신고·심사 규정」일부개정고시(안) 행정예고(식품의약품안전처공고 제2026-434호)9/3/2026
  • 「주문자상표부착수입식품등의 현지 위생점검 기준 및 위생평가 방법」 일부개정고시(안) 행정예고9/2/2026
  • 「한약(생약)제제 등의 품목허가·신고에 관한 규정」 일부개정고시안 행정예고(식품의약품안전처 공고 제2026-418호)8/25/2026
  • 의약품 부작용 피해구제에 관한 규정 일부개정령(안) 입법예고(식품의약품안전처 공고 제2026-408호)8/21/2026

Get MFDS (South Korea) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.